SK17632002A3 - Derivát 5-aminoalkylpyrazolo[4,4-d]pyrimidínu, spôsob jeho prípravy, jeho použitie a liečivo, ktoré ho obsahuje - Google Patents

Derivát 5-aminoalkylpyrazolo[4,4-d]pyrimidínu, spôsob jeho prípravy, jeho použitie a liečivo, ktoré ho obsahuje Download PDF

Info

Publication number
SK17632002A3
SK17632002A3 SK1763-2002A SK17632002A SK17632002A3 SK 17632002 A3 SK17632002 A3 SK 17632002A3 SK 17632002 A SK17632002 A SK 17632002A SK 17632002 A3 SK17632002 A3 SK 17632002A3
Authority
SK
Slovakia
Prior art keywords
methyl
pyrazolo
propyl
chloro
methoxybenzylamino
Prior art date
Application number
SK1763-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Rochus Jonas
Pierre Schelling
Maria Christadler
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK17632002A3 publication Critical patent/SK17632002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK1763-2002A 2000-06-29 2001-06-28 Derivát 5-aminoalkylpyrazolo[4,4-d]pyrimidínu, spôsob jeho prípravy, jeho použitie a liečivo, ktoré ho obsahuje SK17632002A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10031584A DE10031584A1 (de) 2000-06-29 2000-06-29 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
PCT/EP2001/007378 WO2002000660A1 (de) 2000-06-29 2001-06-28 5-aminoalkyl-pyrazolo[4,3-d]pyrimidine mit phosphodiesterase v inhibierender wirkung

Publications (1)

Publication Number Publication Date
SK17632002A3 true SK17632002A3 (sk) 2003-05-02

Family

ID=7647151

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1763-2002A SK17632002A3 (sk) 2000-06-29 2001-06-28 Derivát 5-aminoalkylpyrazolo[4,4-d]pyrimidínu, spôsob jeho prípravy, jeho použitie a liečivo, ktoré ho obsahuje

Country Status (21)

Country Link
US (1) US7060823B2 (ja)
EP (1) EP1296986B1 (ja)
JP (1) JP4964388B2 (ja)
KR (1) KR20030017558A (ja)
CN (1) CN1439011A (ja)
AR (1) AR028772A1 (ja)
AT (1) ATE519761T1 (ja)
AU (2) AU2001279700B2 (ja)
BR (1) BR0111915A (ja)
CA (1) CA2410399C (ja)
CZ (1) CZ20024054A3 (ja)
DE (1) DE10031584A1 (ja)
ES (1) ES2367704T3 (ja)
HU (1) HUP0301587A3 (ja)
MX (1) MXPA02012263A (ja)
NO (1) NO20026247L (ja)
PL (1) PL358551A1 (ja)
RU (1) RU2271359C2 (ja)
SK (1) SK17632002A3 (ja)
WO (1) WO2002000660A1 (ja)
ZA (1) ZA200209728B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942474A1 (de) * 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo[4,3-d]pyrimidine
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
DE10058662A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Pyrazolo[4,3-d]pyrimidinen
UA80871C2 (en) * 2003-04-29 2007-11-12 Pfizer Ltd 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension
OA13050A (en) 2003-04-29 2006-11-10 Pfizer Ltd 5,7-diaminopyrazolo [4,3-D] pyrimidines useful in the treatment of hypertension.
GB0327319D0 (en) * 2003-11-24 2003-12-24 Pfizer Ltd Novel pharmaceuticals
US7572799B2 (en) * 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
GB0327323D0 (en) * 2003-11-24 2003-12-31 Pfizer Ltd Novel pharmaceuticals
ATE417849T1 (de) * 2004-04-07 2009-01-15 Pfizer Pyrazoloä4,3-düpyrimidine
WO2006046135A2 (en) * 2004-10-28 2006-05-04 Pharmacia & Upjohn Company Llc Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors
BRPI0609225A2 (pt) 2005-05-12 2010-03-09 Pfizer formas cristalinas anidras de n-[1-(2-etoxietil)-5-(n-etil-n-metilamino)-7-(4-metilpiridi n-2-il-amino)-1h-pirazolo[4,3-d]pirimidina-3-carbonil] metanossulfonamida, composição farmacêutica compreendendo as mesmas e uso das mesmas
NL2000291C2 (nl) 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
DE102012200360A1 (de) * 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituierte Triazine und ihre Verwendung
CA2782774A1 (en) * 2012-07-06 2014-01-06 Pharmascience Inc. Protein kinase inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075310A (en) * 1988-07-01 1991-12-24 Smith Kline & French Laboratories, Ltd. Pyrimidone derivatives as bronchodilators
JP2657760B2 (ja) 1992-07-15 1997-09-24 小野薬品工業株式会社 ４−アミノキナゾリン誘導体およびそれを含有する医薬品
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9423911D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (de) 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19752952A1 (de) 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE19942474A1 (de) 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo[4,3-d]pyrimidine

Also Published As

Publication number Publication date
EP1296986B1 (de) 2011-08-10
RU2271359C2 (ru) 2006-03-10
JP2004501921A (ja) 2004-01-22
NO20026247D0 (no) 2002-12-27
ATE519761T1 (de) 2011-08-15
HUP0301587A2 (hu) 2003-09-29
AU2001279700B2 (en) 2006-08-24
ZA200209728B (en) 2004-03-12
JP4964388B2 (ja) 2012-06-27
HUP0301587A3 (en) 2005-11-28
CN1439011A (zh) 2003-08-27
CA2410399C (en) 2010-02-16
ES2367704T3 (es) 2011-11-07
MXPA02012263A (es) 2003-04-25
EP1296986A1 (de) 2003-04-02
US7060823B2 (en) 2006-06-13
DE10031584A1 (de) 2002-01-10
BR0111915A (pt) 2003-05-13
AR028772A1 (es) 2003-05-21
US20040029900A1 (en) 2004-02-12
PL358551A1 (en) 2004-08-09
CA2410399A1 (en) 2002-01-03
KR20030017558A (ko) 2003-03-03
WO2002000660A1 (de) 2002-01-03
NO20026247L (no) 2002-12-27
AU7970001A (en) 2002-01-08
CZ20024054A3 (cs) 2003-04-16

Similar Documents

Publication Publication Date Title
US6130223A (en) Thienopyrimidine with phosphodiesterase V inhibiting effect
EP1036078B1 (de) Thienopyrimidine
US6737436B1 (en) Pyrrole derivatives as phosphodiesterase VII inhibitors
SK17632002A3 (sk) Derivát 5-aminoalkylpyrazolo[4,4-d]pyrimidínu, spôsob jeho prípravy, jeho použitie a liečivo, ktoré ho obsahuje
EP1084125B1 (de) Kondensierte thienopyrimidine mit pde v inhibierender wirkung
SK3132002A3 (en) Thienopyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions comprising them
SK10762003A3 (sk) Farmaceutický prostriedok obsahujúci parazolo-[4,3-d]pyrimidíny a nitráty alebo tienopyrimidíny a nitráty
SK17822002A3 (sk) Derivát 2-aminoalkyltieno[2,3-d]pyrimidínu spôsob jeho prípravy, jeho použitie a liečivo, ktoré ho obsahuje
WO2001021620A2 (de) Aminderivate von benzo-4,5-thieno-2,3-d-pyrimidinen
KR20020026011A (ko) 티에노피리미딘의 용도
DE10104096A1 (de) Pharmazeutische Formulierung enthaltend Thienopyrimidine und Nitrate
DE10104801A1 (de) Pharmazeutische Formulierungen enthaltend Thienopirimidine und Endothelin-Rezeptor-Antagonisten (2)
MXPA99001387A (en) Thienopyrimidines